MENU
CHRO
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Channel Therapeutics (CHRO) Ownership - Who owns Channel Therapeutics?
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain... Show more
Profile
Industry
N/A
Address
4400 Route 9 South
Phone
+1 732 514-2636
Employees
7
Web
https://www.chromocell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.52M
P/E Ratio
N/A
Total Cash
1.25M
Projected Growth
N/A
Total Debt
2.29M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CHRO
Capitalization
7.52M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.26M
Total Cash/Share
0.19
Total Debt
2.29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-1.43M
P/B Ratio
4.11
Cash Flow
N/A
Earnings
-1.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
583
Current Ratio
0.60
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-9.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-931.05
Shares Held By Institutions
38.7K
Shares Outstanding - Current
6.6M
Total Liabilities
3.57M
Total Volume MTD
N/A
Value
-1
Gain YTD
77.800
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4400 Route 9 South
Phone
+1 732 514-2636
Employees
7
Web
https://www.chromocell.com